• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY CAROTID WALLSTENT®; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY CAROTID WALLSTENT®; STENT, CAROTID Back to Search Results
Model Number M001719050
Device Problems Fracture (1260); Activation, Positioning or Separation Problem (2906)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/08/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the stent partially deployed and then fractured.The target lesion was located in the severely tortuous and severely calcified right carotid artery.The carotid sheath was backed into the aorta.A 10x31 5.9f 135cm carotid wallstent® was advanced but failed to deliver.As the physician pulled the catheter and the carotid stent back to the sheath, the stent was partially deployed and broke off.The physician removed the stent housing with the partially deployed stent up in the carotid area.The sheath was pushed over the broken stent and the 190cm filterwire ez¿, which had the broken stent within its filter.To prevent blood contamination, everything was pulled out as a unit.The procedure was completed with a different device.No patient complications were reported and the patient's status was fine.
 
Manufacturer Narrative
Device evaluated by manufacturer: the device was returned for analysis.The device was returned with the stent fully mounted onto the delivery system and still loaded onto the customers filterwire.The sheath used during the procedure was not returned for analysis.A visual and tactile examination identified a complete break in the catheter of the device 1186mm distal to the strain relief.Severe stretching damage was identified at the break site on the distal section of the separated device.This type of damage is consistent with excessive force being applied to the delivery system.No issues were noted with the catheter that could have contributed to the compliant incident.The device was returned with the stent fully mounted and constrained on the delivery system.The deployment handle was noted to be fully reconstrained.The investigator noted that the stent was not protruding and no damage was noted to the mounted stent.There was no evidence that the stent had been partially deployed.Due to the condition of the returned device the stent was manually deployed.No resistance or any issues were noted during deployment of the stent.The stent was visually and microscopically examined and no damage or issues were noted with the stent that could have contributed to the complaint incident.A visual and microscopic examination identified no damage or any issues with the stent cups, stent holder or tip of the device that could have contributed to the complaint incident.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is caused by other device as another device/drug/subsequent procedure caused the complaint event.(b)(4).
 
Event Description
It was reported that the stent partially deployed and then fractured.The target lesion was located in the severely tortuous and severely calcified right carotid artery.The carotid sheath was backed into the aorta.A 10x31 5.9f 135cm carotid wallstent was advanced but failed to deliver.As the physician pulled the catheter and the carotid stent back to the sheath, the stent was partially deployed and broke off.The physician removed the stent housing with the partially deployed stent up in the carotid area.The sheath was pushed over the broken stent and the 190cm filterwire ez, which had the broken stent within its filter.To prevent blood contamination, everything was pulled out as a unit.The procedure was completed with a different device.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAROTID WALLSTENT®
Type of Device
STENT, CAROTID
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7393195
MDR Text Key104275265
Report Number2134265-2018-02562
Device Sequence Number1
Product Code NIM
UDI-Device Identifier08714729781127
UDI-Public08714729781127
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/06/2021
Device Model NumberM001719050
Device Catalogue Number71-905
Device Lot Number0021091997
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/14/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/16/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age69 YR
-
-